Literature DB >> 19995586

Controlled in situ preparation of A beta(1-42) oligomers from the isopeptide "iso-A beta(1-42)", physicochemical and biological characterization.

Zsolt Bozso1, Botond Penke, Dóra Simon, Ilona Laczkó, Gábor Juhász, Viktor Szegedi, Agnes Kasza, Katalin Soós, Anasztázia Hetényi, Edit Wéber, Hajnalka Tóháti, Mária Csete, Márta Zarándi, Lívia Fülöp.   

Abstract

Beta-amyloid (A beta) peptides play a crucial role in the pathology of the neurodegeneration in Alzheimer's disease (AD). Biological experiments (both in vitro and animal model studies of AD) require synthetic A beta peptides of standard quality, aggregation grade, neurotoxicity and water solubility. The synthesis of A beta peptides has been difficult, owing to their hydrophobic character, poor solubility and high tendency for aggregation. Recently an isopeptide precursor (iso-A beta(1-42)) was synthesized by Fmoc-chemistry and transformed at neutral pH to A beta(1-42) by O-->N acyl migration in a short period of time. We prepared the same precursor peptide using Boc-chemistry and studied the transformation to A beta(1-42) by acyl migration. The peptide conformation and aggregation processes were studied by several methods (circular dichroism, atomic force and transmission electron microscopy, dynamic light scattering). The biological activity of the synthetic A beta(1-42) was measured by ex vivo (long-term potentiation studies in rat hippocampal slices) and in vivo experiments (spatial learning of rats). It was proven that O-->N acyl migration of the precursor isopeptide results in a water soluble oligomeric mixture of neurotoxic A beta(1-42). These oligomers are formed in situ just before the biological experiments and their aggregation grade could be standardized. (c) 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19995586     DOI: 10.1016/j.peptides.2009.12.001

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  14 in total

1.  Interactions of pathological hallmark proteins: tubulin polymerization promoting protein/p25, beta-amyloid, and alpha-synuclein.

Authors:  Judit Oláh; Orsolya Vincze; Dezsõ Virók; Dóra Simon; Zsolt Bozsó; Natália Tõkési; István Horváth; Emma Hlavanda; János Kovács; Anna Magyar; Mária Szũcs; Ferenc Orosz; Botond Penke; Judit Ovádi
Journal:  J Biol Chem       Date:  2011-08-08       Impact factor: 5.157

2.  Overexpression of Hsp27 ameliorates symptoms of Alzheimer's disease in APP/PS1 mice.

Authors:  Melinda Erzsébet Tóth; Viktor Szegedi; Edina Varga; Gábor Juhász; János Horváth; Emőke Borbély; Balázs Csibrány; Róbert Alföldi; Nikolett Lénárt; Botond Penke; Miklós Sántha
Journal:  Cell Stress Chaperones       Date:  2013-04-21       Impact factor: 3.667

3.  Mechanisms Associated with Type 2 Diabetes as a Risk Factor for Alzheimer-Related Pathology.

Authors:  Men Su; Kambiz Naderi; Nathalie Samson; Ihsen Youssef; Livia Fülöp; Zsolt Bozso; Serge Laroche; Benoit Delatour; Sabrina Davis
Journal:  Mol Neurobiol       Date:  2019-01-25       Impact factor: 5.590

Review 4.  Alzheimer's disease Aβ assemblies mediating rapid disruption of synaptic plasticity and memory.

Authors:  Igor Klyubin; William K Cullen; Neng-Wei Hu; Michael J Rowan
Journal:  Mol Brain       Date:  2012-07-17       Impact factor: 4.041

5.  Acute intracerebral treatment with amyloid-beta (1-42) alters the profile of neuronal oscillations that accompany LTP induction and results in impaired LTP in freely behaving rats.

Authors:  Alexander Nikolai Kalweit; Honghong Yang; Jens Colitti-Klausnitzer; Livia Fülöp; Zsolt Bozsó; Botond Penke; Denise Manahan-Vaughan
Journal:  Front Behav Neurosci       Date:  2015-05-06       Impact factor: 3.558

6.  Abeta(1-42) enhances neuronal excitability in the CA1 via NR2B subunit-containing NMDA receptors.

Authors:  Edina Varga; Gábor Juhász; Zsolt Bozsó; Botond Penke; Lívia Fülöp; Viktor Szegedi
Journal:  Neural Plast       Date:  2014-09-03       Impact factor: 3.599

7.  A foldamer-dendrimer conjugate neutralizes synaptotoxic β-amyloid oligomers.

Authors:  Lívia Fülöp; István M Mándity; Gábor Juhász; Viktor Szegedi; Anasztázia Hetényi; Edit Wéber; Zsolt Bozsó; Dóra Simon; Mária Benkő; Zoltán Király; Tamás A Martinek
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

8.  Simultaneous changes of spatial memory and spine density after intrahippocampal administration of fibrillar aβ1-42 to the rat brain.

Authors:  Emőke Borbély; János Horváth; Szabina Furdan; Zsolt Bozsó; Botond Penke; Lívia Fülöp
Journal:  Biomed Res Int       Date:  2014-06-23       Impact factor: 3.411

9.  Exceptional in vivo catabolism of neurodegeneration-related aggregates.

Authors:  Zsolt Datki; Zita Olah; Tibor Hortobagyi; Lilla Macsai; Katalin Zsuga; Livia Fulop; Zsolt Bozso; Bence Galik; Eva Acs; Angela Foldi; Amanda Szarvas; Janos Kalman
Journal:  Acta Neuropathol Commun       Date:  2018-01-29       Impact factor: 7.801

10.  Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.

Authors:  Anna Ochalek; Balázs Mihalik; Hasan X Avci; Abinaya Chandrasekaran; Annamária Téglási; István Bock; Maria Lo Giudice; Zsuzsanna Táncos; Kinga Molnár; Lajos László; Jørgen E Nielsen; Bjørn Holst; Kristine Freude; Poul Hyttel; Julianna Kobolák; András Dinnyés
Journal:  Alzheimers Res Ther       Date:  2017-12-01       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.